Introduction
============

Liver cancer is one of the most common malignant tumors worldwide ([@b1-or-44-01-0091]), and may be treated with several methods, such as surgery ([@b2-or-44-01-0091]), radiotherapy ([@b3-or-44-01-0091]) and chemotherapy ([@b4-or-44-01-0091]). However, a number of patients miss the opportunity of potentially curative surgical treatment, as the early symptoms of primary liver cancer are not obvious ([@b5-or-44-01-0091]) to enable early diagnosis. The application of radiotherapy and chemotherapy is also limited due to their toxicity and side effects. Therefore, it is crucial to explore the mechanism underlying the occurrence and development of liver cancer and identify novel treatment options.

With the increasing research interest in gut microbiota, the association between gut microbiota and tumors has been gradually elucidated ([@b6-or-44-01-0091],[@b7-or-44-01-0091]). The liver and the gut are connected through the portal vein; therefore, the liver is not only perfused by abundant blood coming from the intestine, but is also affected by the gut microbiota, which may cause chronic inflammation of the liver tissue and increase the risk of liver cancer ([@b8-or-44-01-0091]). It was reported that imbalance of gut microbiota may cause liver tissue damage and cirrhosis, thereby promoting the occurrence of liver cancer ([@b9-or-44-01-0091]). It was also observed that the bacterial metabolite lipopolysaccharide (LPS) promoted liver tissue inflammation by binding to toll-like receptor (TLR)4, which increases the risk of liver cirrhosis and liver cancer ([@b10-or-44-01-0091]). The inflammation of liver tissue also inhibited the function of CD8^+^ T cells and promoted liver cancer by promoting the aggregation of IgA^+^ ([@b11-or-44-01-0091]). Referring to antibiotics as the major class of antibacterial agents, some studies explored their potential in antitumor therapy, and it was reported that bacterial depletion (vancomycin + neomycin + metronidazole + amphotericin) may inhibit the development of pancreatic cancer by restoring the function of CD8^+^ T cells and promoting the polarization and infiltration of M1-like macrophages ([@b7-or-44-01-0091]). It was also reported that bacterial depletion may inhibit the activation of TLR4 to reduce the incidence of liver cancer ([@b9-or-44-01-0091]).

Ciprofloxacin, as a quinolone antibiotic, can be widely used in the treatment of the gastrointestinal tract by interacting with the topoisomerase II-DNA complexes and inhibiting the helix rejoining, thereby forming double-stranded DNA breaks and leading to bacterial death ([@b12-or-44-01-0091]). In addition, ciprofloxacin exerts a certain effect against the eukaryotic topoisomerase IIα, a DNA gyrase analogue ([@b13-or-44-01-0091]). Therefore, it was suggested that ciprofloxacin may inhibit the development of colorectal, pancreatic and breast cancer ([@b14-or-44-01-0091]--[@b16-or-44-01-0091]), among others, through its cytotoxic action, indicating its potential value in the treatment of tumors.

However, the occurrence and development of tumors is a complicated process. In addition to focusing on tumor cells, the role of the tumor microenvironment must not be overlooked ([@b17-or-44-01-0091],[@b18-or-44-01-0091]). It has been demonstrated that the tumor microenvironment may be implicated in the poor efficacy of tumor treatment and drug resistance ([@b19-or-44-01-0091],[@b20-or-44-01-0091]).

Tumor-associated macrophages (TAMs) are an important component of the tumor microenvironment. It was demonstrated that CD206^−^CD86^+^-M1-like macrophages could inhibit tumor development by enhancing antigen presentation, increasing the release of pro-inflammatory factors and promoting phagocytosis ([@b21-or-44-01-0091],[@b22-or-44-01-0091]). Although it has been reported that the use of antibiotics in tumor therapy may promote the conversion of macrophages to M1-like TAMs ([@b7-or-44-01-0091]), the effect of ciprofloxacin on macrophages remains controversial. Some studies reported that ciprofloxacin could inhibit the release of pro-inflammatory factors from macrophages induced by LPS ([@b23-or-44-01-0091]), whereas other studies demonstrated that ciprofloxacin could promote macrophages to release tumor necrosis factor (TNF)-α in a non-bacterial-induced model ([@b24-or-44-01-0091]). Therefore, in the present study, in order to further explore the association between ciprofloxacin, macrophages and liver cancer, the macrophages were treated with different concentrations of ciprofloxacin, the expression of the M1-like macrophage marker CD86 and the M2-like macrophage marker CD206 was detected, and then the effects of ciprofloxacin-induced macrophages (MCIP) on tumor cell proliferation, apoptosis and metastasis of liver cancer were investigated *in vitro* and *in vivo*.

Materials and methods
=====================

### Specimens and patient data

A total of 30 liver cancer specimens were collected from the Pathology Archive of the First Affiliated Hospital of Chongqing Medical University (Chongqing, China) between January 2018 and January 2019, and these 30 liver cancer specimens were used to detect CD206 expression level by immunohistochemistry. The protocol of the present study was approved by the Medical Research Ethics Committee of Chongqing Medical University, and informed consent was obtained from all the patients.

### Immunohistochemical staining

Paraffin sections (7 µm) of tumor tissues were dewaxed at room temperature, rehydrated and heat-treated for antigen retrieval with citric acid buffer at 98°C for 20 min. The sections were then blocked with normal goat serum (C-0005, Bioss) for 30 min, incubated with primary antibody (CD206 1:3,000, cat. no. ab252921, Abcam) at 4°C overnight, and were analyzed using an immunohistochemistry kit (PV-9001, ZSGB-BIO) following standardized protocol. The sections were counterstained with hematoxylin, mounted, and coverslipped. Staining intensity (cytoplasm and membrane) was independently assessed and defined as follows: 0, negative; 1, weak; 2, moderate; and 3, strong. The percentage of positive cells was defined as follows: 0, negative; 1, 1--20%; 2, 21--50%; and 3, 51--100%. The immunohistochemical staining score was calculated as staining intensity × percentage of positive cells and was defined as follows: 0, negative; 1--4, low; and \>4, high.

### Cell culture

Human liver cancer Huh7 and HepG2 cell lines were cultured in RPMI-1640 medium (HyClone; GE Healthcare Life Sciences) supplemented with 10% fetal bovine serum (FBS; Gibco; Thermo Fisher Scientific, Inc.) and 10 U/ml penicillin-streptomycin at 37°C in a 5% CO~2~ incubator. When the density of Huh7 and HepG2 cells reached 70--80%, the cells were processed with 0.5% trypsin and transferred to new dishes. The human monocyte THP-1 cell line was cultured in RPMI-1640 medium (HyClone; GE Healthcare Life Sciences) supplemented with 10% FBS at 37°C in a 5% CO~2~ incubator. A total of 100 ng/ml phorbol-12-myristate-13-acetate (PMA, Sigma-Aldrich; Merck KGaA, cat. no. P1585) was added to the culture medium to induce the transformation of 5×10^6^ monocytes into macrophages (M0) for 24 h. LPS (4 µg/ml; Sigma-Aldrich; Merck KGaA, cat. no. L4391) was added in the culture medium to induce the conversion of M0 into classical (M1-like) macrophages for 48 h. Interleukin (IL)-4 (100 ng/ml) and IL-10 (100 ng/ml) were added in the culture medium to induce the conversion of M0 into non-classical (M2-like) macrophages for 48 h. Various concentrations of ciprofloxacin (0.5, 1, 2.5, 5 and 10 µg/ml) were added in the culture medium to induce the conversion of M0 into ciprofloxacin-induced (MCIP) macrophages; subsequently, the precipitate was removed by centrifugation at 1,000 × g for 10 min at room temperature, and the clear supernatant extract of M0 and MCIP macrophages at 6, 12 and 24 h was collected to make a conditioned medium.

### Western blotting

For the western blot analyses, RIPA buffer containing protease inhibitors and phosphatase inhibitors (Roche Diagnostics) was used to prepare whole-cell lysates. Protein (20 µg) from the lysates was separated by 10% SDS-PAGE and transferred to a PVDF membrane (0.45 µm, EMD Millipore). The membrane was blocked in 5% BSA (cat. no. A8020, Solarbio Life Science) at 37°C for 2 h. After overnight incubation at 4°C with primary antibodies (CD206 1:1,000, cat. no. ab252921, Abcam; Bcl2 1:1,000, cat. no. 15071, Cell Signaling Technology, Inc.; Bax 1:1,000, cat. no. 2774, Cell Signaling Technology, Inc.; p-AKT 1:1,000, cat. no. 4060, Cell Signaling Technology, Inc.; AKT 1:1,000, cat. no. 4685, Cell Signaling Technology, Inc.; CD86 1:1,000, YM0137, Immunoway; and β-actin 1:1,000, TA-09, ZSGB-BIO), the membranes were washed 3 times with 0.1% TBST (5 min per wash). After incubating with horseradish peroxidase-conjugated anti-mouse/rabbit IgG (1:3,000, cat. no. ZDR-5307/5306, ZSGB-BIO) at 37°C for 1 h, the membranes were examined by enhanced chemiluminescence (cat. no. P0018AS, Beyotime Institute of Biotechnology).

### RT-quantitative-PCR (RT-qPCR) analysis

Total RNA was extracted from Huh7 or HepG2 cells by TRIzol (TaKaRa Bio) and PrimeScriptTM RT Master Mix transcription kit (TaKaRa Bio) was used to reverse-trasncribe RNA into cDNA. The reverse transcription conditions were as follows: i) 37°C for 15 min; ii) 85°C for 5 sec. qPCR was performed in a CFX-connect fast real-time PCR system (Bio-Rad Laboratories, Inc.). The sample mixture was composed of 5 µl SYBR (TaKaRa Bio), 0.8 µl primers, 1 µl cDNA, and 3.2 µl ddH~2~O. The thermocycling conditions were as follows: i) 95°C for 10 min; ii) 95°C for 20 sec; iii) 56°C for 10 sec; iv) the temperature was reduced by 3°C/cycle and steps ii-iv were repeated for 35 cycles; v) 95°C for 20 sec; and vi) 55°C for 20 sec.

The sequences of the primers used were as follows: TNF-α: Forward, 5′-GCCAACGGCATGGATCTCAA-3′ and reverse, 5′-CAGCCTTGTCCCTTGAAGAGAAC-3′; IL-1β: Forward, 5′-GAAATGATGGCTTATTACAGTGGC-3′ and reverse, 5′-TAGTGGTGGTCGGAGATTCGTAG-3′.

### MTT

Huh7 and HepG2 cells (2×10^3^/well) were inoculated into a 6-well plate and maintained in an incubator at 37°C with 5% CO~2~ for ≤4 days. Cells in each well were treated with 10 µl MTT (5 mg/ml) for 4 h at 37°C. The medium was removed, and cells were lysed with 200 µl DMSO for 30 min. Cell viability was measured at 492 nm using an ELISA plate reader (BioTek Instruments, Inc.).

### Crystal violet staining

Huh7 and HepG2 cells (3×10^4^/well) were inoculated into a 24-well plate and the conditioned medium was added in each well for 48 h. The medium was removed and 500 µl 4% paraformaldehyde was added in each well at room temperature for 30 min, then cells were dyed by 500 µl 1% crystal violet solution at room temperature for 30 min. The cells were lysed with 200 µl glacial acetic acid and measured at 592 nm using an ELISA plate reader (BioTek Instruments, Inc.).

### Hoechst staining

Huh7 and HepG2 cells (5×10^4^/well) were inoculated into a 6-well plate, and treated with conditioned medium for 48 h, fixed with 4% paraformaldehyde and stained with 10 ng/ml Hoechst 33258 solution (Solarbio, cat. no. C0021). Increased condensation of chromatin was observed in apoptotic cells. Apoptotic cells were captured with an inverted fluorescence microscope (Nikon 80i; Nikon Corporation) in 3 random fields per experiment (magnification, ×100).

### Wound healing test

When the cell density reached \>80% in the 6-well plate, conditioned medium with 1% FBS of M0 or MCIP was added in the 6-well plate. The cells were scratched with a small 10-µl pipette tip and washed with PBS 3 times (30 sec/per wash) before being observed and photographed under a microscope (Nikon 80i) at 0 and 24 h (magnification, ×100). Then, the wound width was recorded at the same observation point. The mean wound width of multiple observation points was calculated, and the wound healing rate of each group was obtained.

### Transwell assay

Transwell inserts (24-well, with an 8.0-µm pore polycarbonate membrane) were purchased from Corning, Inc. (cat. no. 3422). Matrigel (50 µl; cat. no. 356234, Corning, Inc.) was used in the invasion experiment; the volume ratio of Matrigel and culture medium was 1:5. M0 or MCIP conditioned medium (400 µl) with 10% FBS containing 40,000 Huh7 cells or 40,000 HepG2 cells was added to each upper chamber, and 700 µl RPMI-1640 medium containing 15% FBS was added to the lower chamber. Four parallel controls were set up in each group. After 24 h, the cells on the lower side of the chamber membrane were fixed for 20 min with 500 µl 4% paraformaldehyde at room temperature. The cells were stained with 500 µl 1% crystal violet solution for 30 min at room temperature. After washing and drying, the cells were counted under a microscope (Nikon 80i) at a magnification of ×100. At least 10 visual fields were observed in each chamber, and the mean values were obtained after counting.

### In vivo experiment

A total of 14 specific pathogen-free male BALB/c nude mice, aged 6 weeks and weighing 20±1 g, were purchased from HFK Bioscience Co. Ltd. The nude mice were randomly divided into two groups (Huh7 group, n=5; Huh7 + MCIP group, n=9). Huh7 cells (5×10^6^) with or without MCIP (1×10^7^) were suspended in 100 µl PBS, and then inoculated into the subcutaneous region of the right upper armpit of the nude mice. The tumors were resected 3 weeks after implantation. The length (a) and width (b) of each tumor were measured, and the tumor volume (V) was calculated as follows: V = a × b^2^ × π/6. The experimental procedures, which ensured the safety of practitioners in laboratory animal projects and conformed to ethical standards and international practices, were approved by the Animal Experimental Ethics Committee of Chongqing Medical University. The animals were fed a standard laboratory diet with free access to food and water, and were kept in a room at controlled temperature (22±1°C) and humidity (65-70%), with a 12-h light-dark cycle. After the study, all animals were anaesthetized by isoflurane inhalation (1.5--2%) and then euthanized by cervical dislocation. All animal experiments conformed to the guidelines from Directive 2010/63/EU of the European Parliament on the protection of animals used for scientific purposes.

### Statistical analysis

SPSS 16.0 statistical software (SPSS, Inc.) was used to analyze the experimental results. Each experiment was repeated three times. The differences between groups were evaluated by t-test or Bonferroni-corrected t-test. P\<0.05 was considered to indicate statistically significant differences.

Results
=======

### Ciprofloxacin promotes CD86^+^CD206^−^ macrophage polarization

Among macrophages, which are an important component of the tumor microenvironment, non-classical (M2-like) macrophages can promote tumors, while classical (M1-like) macrophages can inhibit tumors. In accordance with existing reports, the immunohistochemistry examination demonstrated that the expression of CD206, a marker of M2-like macrophages, was higher in the low-differentiation group compared with that in the high-differentiation group ([Fig. 1A](#f1-or-44-01-0091){ref-type="fig"}).

To investigate the association between ciprofloxacin and macrophage polarization, M0 macrophages were exposed to ciprofloxacin (MCIP) at various concentrations. The western blot analysis revealed that the M1-like macrophage-related marker CD86 was upregulated ([Fig. 1B and E](#f1-or-44-01-0091){ref-type="fig"}), while the protein levels of Bcl2 and BAX were not affected by ciprofloxacin ([Fig. 1B-D](#f1-or-44-01-0091){ref-type="fig"}); accordingly, in the subsequent experiments, 2 µg/ml ciprofloxacin was used to treat macrophages. When using M1-like and M2-like macrophages as a reference, it was observed that CD86 was upregulated in M0 by ciprofloxacin treatment; by contrast, the M2-like macrophage-related marker CD206 was downregulated ([Fig. 1F-H](#f1-or-44-01-0091){ref-type="fig"}). Subsequently, the expression of cytokines was investigated and it was observed that the pro-inflammatory factors TNF-α and IL-1β were upregulated in M1-like and MCIP macrophages ([Fig. 1I and J](#f1-or-44-01-0091){ref-type="fig"}); by contrast, these cytokines were downregulated in M2-like macrophages.

### Effect of MCIP on the proliferation and apoptosis of liver cancer cells

It was observed in previous experiments that ciprofloxacin increased the number of CD86^+^CD206^−^ macrophages, but it was uncertain whether this group of macrophages exerted a tumor-suppressive effect similar to that of M1-like macrophages; therefore, the following experiment was conducted: The conditioned medium of MCIP was collected to treat HepG2 and Huh7 cells. MTT assay demonstrated that the OD values did not differ significantly between the groups on days 0, 1 and 2. However, on day 3, the OD values of HepG2 ([Fig. 2A](#f2-or-44-01-0091){ref-type="fig"}) and Huh7 ([Fig. 2B](#f2-or-44-01-0091){ref-type="fig"}) cells in the MCIP conditioned medium group were significantly lower compared with those in the control group. The results of crystal violet staining revealed that the number of HepG2 ([Fig. 2C and D](#f2-or-44-01-0091){ref-type="fig"}) and Huh7 ([Fig. 2E and F](#f2-or-44-01-0091){ref-type="fig"}) cells was lower in the MCIP group compared with the M0 group. These results demonstrated that macrophages inhibited the proliferation of liver cancer cells to a greater extent following ciprofloxacin treatment. To investigate the effect of MCIP on the apoptosis of liver cancer cells, Hoechst staining was used, and it demonstrated typical apoptotic changes of the nuclei of HepG2 ([Fig. 2G and H](#f2-or-44-01-0091){ref-type="fig"}) and Huh7 ([Fig. 2I and J](#f2-or-44-01-0091){ref-type="fig"}) cells in the MCIP conditioned medium group, and that the numbers of HepG2 and Huh7 cells in the MCIP conditioned medium group were lower compared with those in the control group. To compare with the results of previous studies, it was reported that the protein levels of Bcl2 were downregulated in Huh7 cells ([Fig. 3E and F](#f3-or-44-01-0091){ref-type="fig"}) and were unaffected in HepG2 cells ([Fig. 3A and B](#f3-or-44-01-0091){ref-type="fig"}), while BAX was upregulated in Huh7 ([Fig. 3E and G](#f3-or-44-01-0091){ref-type="fig"}) and HepG2 ([Fig. 3A and C](#f3-or-44-01-0091){ref-type="fig"}) cells. However, the Bcl2/BAX ratio was decreased in HepG2 ([Fig. 3D](#f3-or-44-01-0091){ref-type="fig"}) and Huh7 ([Fig. 3H](#f3-or-44-01-0091){ref-type="fig"}) cells following treatment with MCIP conditioned medium.

### Effect of MCIP on the migration and invasion of liver cancer cells

To explore the role of MCIP in metastasis, the wound healing test was used. It revealed that the migration abilities of HepG2 ([Fig. 4I and J](#f4-or-44-01-0091){ref-type="fig"}) and Huh7 ([Fig. 4K and L](#f4-or-44-01-0091){ref-type="fig"}) cells were inhibited by treatment with MCIP conditioned medium. To verify the effect of MCIP on the migration abilities of HepG2 and Huh7 cells, Transwell assays without Matrigel revealed that the transmembrane numbers of HepG2 ([Fig. 4A and B](#f4-or-44-01-0091){ref-type="fig"}) and Huh7 ([Fig. 4C and D](#f4-or-44-01-0091){ref-type="fig"}) cells were lower in the MCIP conditioned group compared with those in the control group. The Transwell assay with Matrigel was used to verify the effect of MCIP on the invasion abilities of HepG2 ([Fig. 4E and F](#f4-or-44-01-0091){ref-type="fig"}) and Huh7 ([Fig. 4G and H](#f4-or-44-01-0091){ref-type="fig"}). The results revealed that the transmembrane numbers of Huh7 and HepG2 cells were lower in the MCIP conditioned group compared with those in the control group.

### Effect of the phosphatidylinositol 3-kinase (P13K)/AKT signaling pathway on the regulation of liver cancer cells by MCIP

PI3K/AKT has been proven to play a key role in the pathogenic process of tumors. To verify whether this signaling pathway was involved in regulating liver cancer, western blotting was used. The results revealed that the level of phosphorylated AKT (p-AKT) was downregulated in HepG2 ([Fig. 5A](#f5-or-44-01-0091){ref-type="fig"}) and Huh7 ([Fig. 5C](#f5-or-44-01-0091){ref-type="fig"}) cells by adding MCIP conditioned medium compared with the control group, whereas the total AKT level did not differ between the MCIP conditioned medium and control groups ([Fig. 5A and C](#f5-or-44-01-0091){ref-type="fig"}). Therefore, the p-AKT/AKT ratio was decreased in HepG2 ([Fig. 5B](#f5-or-44-01-0091){ref-type="fig"}) and Huh7 ([Fig. 5D](#f5-or-44-01-0091){ref-type="fig"}) cells after treatment with MCIP conditioned medium.

### Effect of MCIP on Huh7 cells in vivo

To demonstrate the effect of MCIP on liver cancer cells *in vivo*, the subcutaneous tumorigenicity test was used. Huh7 cells were used, as the tumorigenesis rate of Huh7 cells was higher compared with that of HepG2 cells. Huh7 cells (5×10^6^) were injected into the armpit of nude mice together with 1×10^7^ ciprofloxacin-treated macrophages (MCIP) to construct a subcutaneous tumor model. As expected, the tumor size of the Huh7 + MCIP group was smaller compared with that of the Huh7 group ([Fig. 5E and F](#f5-or-44-01-0091){ref-type="fig"}). The results of the *in vivo* experiments were consistent with those of the *in vitro* experiments.

Discussion
==========

Liver cancer is one of the most common malignant tumors worldwide. The annual death toll of patients with liver cancer is reported to be as high as 745,000. The occurrence and development of liver cancer is a complex process involving multiple factors. Due to the insidious symptoms at the early stages of liver cancer, the majority of the patients miss the opportunity for surgical treatment. Moreover, the efficacy of other conventional treatments, such as chemotherapy, radiotherapy and molecular targeted drugs, has also been limited in clinical application due to the associated toxic side effects and drug resistance ([@b25-or-44-01-0091]--[@b28-or-44-01-0091]). Consequently, the development of preventive or therapeutic strategies adopting novel mechanisms, such as the application of antibiotics targeting liver cancer-related immunity mechanisms, is imminent.

Ciprofloxacin belongs to the class of quinolone antibiotics ([@b29-or-44-01-0091]). Its main mechanism of antibacterial activity is to inhibit bacterial DNA replication and division by acting on the topoisomerase II and topoisomerase IV of bacteria. However, mammalian topoisomerase II is also one of the targets of certain antitumor drugs ([@b30-or-44-01-0091]). Due to the similarities in the DNA synthesis mechanism for topoisomerase II between mammals and bacteria, quinolone antibiotics have also been investigated in the field of antitumor research. It was demonstrated that ciprofloxacin could induce apoptosis of tumor cells through its cytotoxic action ([@b14-or-44-01-0091]--[@b16-or-44-01-0091]).

Although numerous studies have investigated the direct effects of ciprofloxacin on tumors, there are only few studies on the effects of ciprofloxacin on the components of the tumor microenvironment, such as TAMs. In the present study, it was observed that ciprofloxacin at 0.5, 1, 2.5, 5 and 10 µg/ml promoted the expression of CD86, which was highly expressed in M1-like TAMs ([@b31-or-44-01-0091],[@b32-or-44-01-0091]), while the expressions of IL-1β and TNF-α were also increased; conversely, the expression of the CD206, which was highly expressed in M2-like TAMs ([@b33-or-44-01-0091]--[@b35-or-44-01-0091]), was reduced. TAMs are a complex group, and each member exhibits various biological characteristics and functions. Some studies confirmed that M1-like TAMs had strong phagocytic and antigen-presenting abilities, and secreted a large number of pro-inflammatory factors, which contributed to bacterial elimination and antitumor immunity ([@b36-or-44-01-0091],[@b37-or-44-01-0091]); on the contrary, M2-like TAMs exhibited reduced phagocytic and antigen-presenting abilities, and could secrete anti-inflammatory factors to suppress the immune response and promote tumor progression ([@b33-or-44-01-0091],[@b38-or-44-01-0091],[@b39-or-44-01-0091]). It was observed herein that ciprofloxacin promoted the expression of CD86 and inhibited the expression of CD206. This result suggested that ciprofloxacin may be involved in the regulation of M0 TAMs to CD86^+^CD206^−^-M1-like macrophages. Accordingly, in order to elucidate whether the macrophages treated with ciprofloxacin promote tumor inhibition, in-depth investigation and analysis were conducted in this study.

Due to the regulatory interaction between tumor cells and TAMs ([@b40-or-44-01-0091]), in order to avoid the interference of tumor cells in MCIP, the method of co-culture was excluded, and MCIP conditioned medium was prepared to verify the MCIP function. It was demonstrated that the MCIP conditioned medium could inhibit the proliferation of liver cancer cells by MTT assay, while crystal violet staining, Hoechst staining and the Bcl2/BAX ratio demonstrated that the addition of MCIP conditioned medium could reduce the number of liver cancer cells and promote cell apoptosis. In addition, the caspase pathway and the presence of phosphatidylserine on the exterior surface of the plasma membrane may also be used to verify the effect of ciprofloxacin on cell apoptosis; therefore, the mechanism through which MCIP conditioned medium regulates apoptosis of liver cancer cells required further investigation. Transwell and wound healing experiments revealed that the addition of MCIP conditioned medium inhibited the migration and invasion of liver cancer cells, and downregulated the level of p-AKT. It was also observed *in vivo* that the subcutaneous tumors of nude mice that had received MCIP treatment were smaller. In summary, MCIP conditioned medium inhibited the proliferation, migration and invasion of liver cancer cells, as well as subcutaneous tumor formation, and promoted apoptosis. However, due to the limitation of conditioned medium preparation in this study, conditioned medium containing 1% FBS was used for the wound healing experiments. Therefore, in order to exclude the interference of proliferation, in addition to the Transwell assay, more experiments are required to verify the effect of MCIP on the migration and invasion of liver cancer cells. Furthermore, the composition of the conditioned medium is complicated, and the contributions made by specific cytokines towards the overall regulatory function require follow-up experiments to verify.

The occurrence and development of tumors is a complex process, and the effect of the tumor microenvironment is suggested to be significant, particularly in promoting tumors and inhibiting the effects of drug treatment ([@b19-or-44-01-0091],[@b20-or-44-01-0091]). It was previously confirmed that M2-like TAMs promote tumor angiogenesis by secreting vascular endothelial growth factor ([@b41-or-44-01-0091]), degrade extracellular matrix by inducing the secretion of matrix metallopeptidases, promote vascular endothelial cell migration and facilitate tumor cell metastasis ([@b42-or-44-01-0091],[@b43-or-44-01-0091]). Therefore, the investigation of macrophages as a therapeutic target may be of considerable value in tumor immunotherapy. It was observed in the present study that ciprofloxacin could increase the number of CD86^+^CD206^−^ macrophages and inhibit the progression of liver cancer, which further elucidated the mechanism and potential of ciprofloxacin in the treatment of liver cancer. The results revealed that ciprofloxacin-induced macrophages (MCIP) highly expressed CD86, TNF-α and IL-1β; however, in other experiments, it was confirmed that MCIP could regulate the proliferation, metastasis and apoptosis of liver cancer, which was similar to the functions of M1-like TAMs. However, the classification of TAMs is complicated. In addition to the classical CD86 and CD206, CD163, CD204, CD200R and some cytokines may also be used for the identification of M1-like and M2-like macrophages ([@b44-or-44-01-0091],[@b45-or-44-01-0091]). Although increased expression levels of CD86, TNF-α and IL-1β were observed, the decreased expression of CD206 in macrophages after treatment with ciprofloxacin and MCIP also exerted some tumor-inhibitory effects. However, other studies reported that ciprofloxacin could promote the expression of TNF-α and did not affect the expression of IL-1β in animal models ([@b46-or-44-01-0091]). The changes in these cytokines were not consistent with the classical model of LPS-induced M1-like macrophage polarization ([@b47-or-44-01-0091]). Thus, although MCIP overexpressed CD86 with low expression of CD206 and exhibited the similar tumor-suppressive trend as M1-like TAMs, the identification of macrophage types prone to MCIP requires more indicators for validation.

It was previously reported that ciprofloxacin could inhibit the secretion of TNF-α and IL-1β from microglia and other cells following stimulation by LPS ([@b23-or-44-01-0091]), but other studies reported that ciprofloxacin could promote the expression of TNF-α and reduce the expression of IL-10 ([@b48-or-44-01-0091]), which suggested that ciprofloxacin played different roles in different disease models and different types of immune cells. In order to investigate the effect of ciprofloxacin on TAMs in our experiments, an experimental model of THP-1 monocytes transforming into macrophages was induced by the addition of PMA ([@b49-or-44-01-0091],[@b50-or-44-01-0091]). Therefore, in the follow-up study, extraction of primary TAMs will be planned to explore the regulation on macrophage function by ciprofloxacin. In order to explore the effect of MCIP on tumor development, MCIP conditioned medium was adopted to observe the effect of MCIP on liver cancer cell proliferation, apoptosis, migration and invasion, while the effect on tumor occurrence resulting from the interaction between oncogenic cells and the microenvironment was investigated. Although it has been reported that tumor cells could regulate the transformation of TAMs to M2-like TAMs through various pathways, in our experiments, only the effects of MCIP on tumors were explored, whereas the possible regulatory effects of tumor cells on MCIP were not. Therefore, in the follow-up study, the experimental design should take into consideration both aspects of tumor cell-MCIP interactions, to further elucidate the association between ciprofloxacin, TAMs and liver cancer.

Although a number of studies confirmed that ciprofloxacin may be used to inhibit the development of a wide range of tumors, ciprofloxacin cannot differentiate between tumor cells and normal tissue, as it targets topoisomerases of all eukaryotes ([@b51-or-44-01-0091]). While ciprofloxacin directly acts on tumor cells, it may also damage normal cells, inducing certain adverse reactions. In addition, drug resistance is also an unavoidable limitation of this antibiotic ([@b52-or-44-01-0091]). It was observed in the experiment that ciprofloxacin-induced MCIP exerted a certain inhibitory effect on tumors, but similar to M1-like macrophages, their inhibitory effects on cells were not cell-specific. It was reported that M1-like macrophage overactivation may be associated with cardiovascular ([@b53-or-44-01-0091]), autoimmune ([@b54-or-44-01-0091]) and metabolic ([@b55-or-44-01-0091]) diseases, so extensive investigation is still required before the clinical application of ciprofloxacin in antitumor therapy. More in-depth research is required to verify the effect of ciprofloxacin on macrophage polarization and to further explore its specific regulatory mechanisms.

In summary, the present study further elucidated the biological mechanism underlying the potential applicability of ciprofloxacin in antitumor therapy and indicated new potential targets for the treatment of liver cancer.
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:   serine/threonine kinase
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![Ciprofloxacin promotes CD86^+^CD206^−^ macrophage polarization. (A) The expression of CD206 in highly and poorly differentiated liver cancer tissues by immunohistochemistry (low differentiation, n=15; high differentiation, n=15). (B) The protein levels of CD86, Bcl2 and BAX were detected by western blotting in macrophages after treatment with different concentrations of ciprofloxacin. Densitometry analysis was used to quantify the expression of (C) Bcl2, (D) BAX and (E) CD86 (\*P\<0.05 \*\*P\<0.005 \*\*\*P\<0.001 vs. 0 µg/ml group). (F) The protein levels of CD86 and CD206 were detected by western blotting in M0 macrophages (M0), M1-like macrophages (M1), M2-like macrophages (M2) and ciprofloxacin-induced macrophages (MCIP). Densitometry analysis was used to quantify the expression of (G) CD86 (\*P\<0.05 vs. M2 group) and (H) CD206 (\*\*P\<0.005 vs. M2 group). (I) The mRNA level of TNF-α was detected by quantitative PCR in the M0, M1, M2 and MCIP groups (\*\*P\<0.005 vs. M2 group). (J) The mRNA level of IL-1β was detected by quantitative PCR in the M0, M1, M2 and MCIP groups (\*\*P*\<*0.005 vs. M2 group). TNF tumor necrosis factor; IL, interleukin.](OR-44-01-0091-g00){#f1-or-44-01-0091}

![Effect of MCIP on the proliferation and apoptosis of liver cancer cells. (A) The proliferation ability of HepG2 cells after treatment with conditioned medium from M0 or MCIP macrophages was detected by MTT assay (\*P\<0.05 vs. M0 group). (B) The proliferation ability of Huh7 cells after treatment with conditioned medium from M0 or MCIP macrophages was detected by MTT assay (\*\*P\<0.005 vs. M0 group). (C) The number of HepG2 cells after treatment with conditioned medium was detected by crystal violet staining. (D) Quantitative result of crystal violet staining of HepG2 cells (\*\*P\<0.005 vs. M0 group). (E) The number of Huh7 cells after treatment with conditioned medium was detected by crystal violet staining. (F) Quantitative result of crystal violet staining of Huh7 cells (\*\*P\<0.005 vs. M0 group). (G) The apoptosis of HepG2 cells after treatment with conditioned medium was detected by Hoechst staining. (H) The number of HepG2 cells was measured (\*\*P\<0.005 vs. M0 group). (I) The apoptosis ability of Huh7 was detected by Hoechst staining. (J) The number of HepG2 cells was measured (\*\*P\<0.005 vs. M0 group). MCIP, ciprofloxacin-induced macrophages.](OR-44-01-0091-g01){#f2-or-44-01-0091}

![Effect of MCIP on apoptosis of liver cancer cells. (A) The protein levels of Bcl2 and BAX of HepG2 cells after treatment with conditioned medium from M0 or MCIP macrophages were detected by western blotting. Densitometry analysis was used to quantify the expression of (B) Bcl2, (C) BAX and (D) Bcl2/BAX (\*\*P\<0.005 vs. M0 group). (E) The protein levels of Bcl2 and BAX in Huh7 cells after treatment with conditioned medium were detected by western blotting. Densitometry analysis quantify the expression of (F) Bcl2, (G) BAX and (H) Bcl2/BAX (\*\*P\<0.005 vs. M0 group; \*\*\*P\<0.001 vs. M0 group). MCIP, ciprofloxacin-induced macrophages; ns, not significant.](OR-44-01-0091-g02){#f3-or-44-01-0091}

###### 

Effect of MCIP on migration and invasion of liver cancer cells. (A and B) The migration ability of HepG2 cells was analyzed by Transwell assay without Matrigel after treatment with conditioned medium from M0 or MCIP macrophages (\*\*\*P\<0.001 vs. M0 group). (C and D) The migration ability of Huh7 cells was analyzed by Transwell assay without Matrigel after treatment with conditioned medium from M0 or MCIP macrophages (\*\*P\<0.005 vs. M0 group). (E and F) The migration ability of HepG2 cells was analyzed by Transwell assay with Matrigel after treatment with conditioned medium from M0 or MCIP macrophages (\*\*\*P\<0.001 vs. M0 group). (G and H) The migration ability of Huh7 cells was analyzed by Transwell assay with Matrigel after treatment with conditioned medium from M0 or MCIP macrophages (\*\*\*P\<0.001 vs. M0 group). (I and J) The metastatic ability of HepG2 cells after treatment with conditioned medium from M0 or MCIP macrophages was examined by wound healing test (\*P\<0.05 vs. M0 group). (K and L) The metastasis ability of Huh7 cells after treatment with conditioned medium from M0 or MCIP macrophages was performed by wound healing test (\*\*P\<0.005 vs. M0 group). MCIP, ciprofloxacin-induced macrophages.
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![Effect of the PI3K/AKT signaling pathway on the regulation of liver cancer cells by MCIP and the effect of MCIP on liver cancer cells *in vivo*. (A) The protein levels of p-AKT and AKT in HepG2 cells after treatment with conditioned medium from M0 or MCIP macrophages were detected by western blotting. (B) Densitometry analysis was used to quantify the expression of p-AKT/AKT (\*\*P\<0.005 vs. M0 group). (C) The protein levels of p-AKT and AKT in Huh7 cells after treatment with conditioned medium from M0 or MCIP macrophages were detected by western blotting. (D) Densitometry analysis was used to quantify the expression of p-AKT/AKT (\*\*P\<0.005 vs. M0 group). (E) The Huh7 tumors were resected from nude mice 3 weeks after tumor implantation (Huh7 group, n=5; Huh7 + MCIP group, n=9). (F) Statistical analysis of tumor volume (\*P*\<*0.05 vs. M0 group). PI3K, phosphatidylinositol 3-kinase; MCIP, ciprofloxacin-induced macrophages.](OR-44-01-0091-g05){#f5-or-44-01-0091}
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